{
  "experiment_id": "625fe1450ca6754ee3e4b81d7c177dc7",
  "task_name": "broadening_of_narrow_synonyms",
  "task_hash": "a2c885aa2a82bb5b150f213062bbeb89",
  "model_id": "google/gemini-3-pro-preview",
  "system_instructions": "You are a metadata curation assistant. Your task is to help improve and correct metadata \naccording to the specific instructions provided for each task. Be precise, accurate, and \nfollow the guidelines carefully.\n",
  "temperature": 0.0,
  "thinking": false,
  "tools": [],
  "timestamp": "2025-11-19T20:16:26.535002",
  "task_result": {
    "task_name": "broadening_of_narrow_synonyms",
    "num_samples": 10,
    "results": [
      {
        "sample_index": 0,
        "input": {
          "diagnosis": "Neurofibromatosis type 1 microdeletion syndrome",
          "assay": "clinical whole-exome sequencing",
          "tumorType": "Plexiform neurofibroma (morphologic abnormality)"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Plexiform Neurofibroma\"\n}\n```",
          "model_id": "google/gemini-3-pro-preview",
          "usage": {
            "inputTokens": 2579,
            "outputTokens": 572,
            "totalTokens": 3151
          },
          "attempt": 1,
          "raw_response": {
            "id": "gen-1763583285-4I9TX775y4JvbkKojUaX",
            "provider": "Google AI Studio",
            "model": "google/gemini-3-pro-preview",
            "object": "chat.completion",
            "created": 1763583285,
            "choices": [
              {
                "logprobs": null,
                "finish_reason": "stop",
                "native_finish_reason": "STOP",
                "index": 0,
                "message": {
                  "role": "assistant",
                  "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Plexiform Neurofibroma\"\n}\n```",
                  "refusal": null,
                  "reasoning": "**Broadening Terms:**\n\nI'm currently working to broaden the specific diagnostic term \"Neurofibromatosis type 1 microdeletion syndrome\" into something more general, aligning with the target schema. Similarly, the assay \"clinical whole-exome sequencing\" will need to be adjusted to a more standard term. I'm focusing on finding the appropriate general terms that maintain the core meaning while conforming to broader accepted standards.\n\n\n**Confirming Schema Adherence:**\n\nI've just successfully mapped the \"tumorType\" input to the appropriate schema term: \"Plexiform Neurofibroma\". I verified that \"Plexiform neurofibroma (morphologic abnormality)\" is accurately represented by the simpler, standardized term. The diagnostic terms and assay are now successfully mapped and adhere to the target schema.\n\n\n**Generating the Output**\n\nI've completed the validation steps. The `diagnosis`, `assay`, and `tumorType` values all match the permitted entries within the schema. This confirms the validity of the data. I'm confident now in generating the final JSON response, which I will begin producing. I'll focus now on formatting the JSON to ensure it's easy to read and correctly structured.\n\n\n",
                  "reasoning_details": [
                    {
                      "format": "google-gemini-v1",
                      "index": 0,
                      "type": "reasoning.text",
                      "text": "**Broadening Terms:**\n\nI'm currently working to broaden the specific diagnostic term \"Neurofibromatosis type 1 microdeletion syndrome\" into something more general, aligning with the target schema. Similarly, the assay \"clinical whole-exome sequencing\" will need to be adjusted to a more standard term. I'm focusing on finding the appropriate general terms that maintain the core meaning while conforming to broader accepted standards.\n\n\n**Confirming Schema Adherence:**\n\nI've just successfully mapped the \"tumorType\" input to the appropriate schema term: \"Plexiform Neurofibroma\". I verified that \"Plexiform neurofibroma (morphologic abnormality)\" is accurately represented by the simpler, standardized term. The diagnostic terms and assay are now successfully mapped and adhere to the target schema.\n\n\n**Generating the Output**\n\nI've completed the validation steps. The `diagnosis`, `assay`, and `tumorType` values all match the permitted entries within the schema. This confirms the validity of the data. I'm confident now in generating the final JSON response, which I will begin producing. I'll focus now on formatting the JSON to ensure it's easy to read and correctly structured.\n\n\n"
                    },
                    {
                      "format": "google-gemini-v1",
                      "index": 0,
                      "type": "reasoning.encrypted",
                      "data": "EokSCoYSAdHtim9hFw4Ckkn+ymIjas2WIA3230gFAnY0a86szFoZmyDySVvM5VWE4xvlrpEb9gz0I4moYuU+M57UteWNcscKByxtI0yEs6EM/vJg582UkPvzTFEl43LfuOWNbhaqYCI8iNEDkzof7SKJlEs+jkTKtCd7RcoQZQzfWxmYyVb2yXghm74mzeFNgPuZuQE3lOShkBdvMWBBVHfP9gmmMTbTbHR4+n2jfRJr2037/WS0alsw59eS0qvg5z/Li4OOLxh0FkQM/VsBjxivZAb6zRoaoed/fGQrwu9BgG+SzlFRtpJT8o5ybbu0c5qwknakJnNBm5UFAByC9+CV0eWBUIIKihKXxtILgwgo9obOAkc0SsMqQCn82Xoj8yxsewH/wUEdtU6ERwvaVmhPA43QOdWhzPrszST8Mw7ivOp2oyTB0SgOXNuBRbISD6mLfax2w5ZsWufXOen5+qm5fS+MUhJCKjUrc45TZ478lc7ckjwvvzDC0q9E+glu7+NnUKhzJ1FqxcRDUtm9oqRx4Z97SgvPoY/RwGZN4Pf0TGQfax1vD4M40YbGZrTsoRdkqZnNdnEegBQlexevXhNapYswuzPUHHieQ9drTCupCLU9P2HbzqcesnxxTkzhz67BdRAcGqOT1u4uDcN00CL7iAL7XMspI/HFYRleCIMItxzaJWvaIMmFoQWw/3dp5DLvAqUYVApz3zHsIH0xOS6VrORuEVU9ABnRRg3ZZG8UF2DCrr+IBk9psQCn7RFhzDA0oHe1mCmhGjciqcgdMk/Te4Y+VnhPt5KPrINBrjAmvlYumuMRy0Lv4bfplILukDgekQ3D3y/dEYGs2HSih+Jad0PQ6CIzWY8tKFmx+g1Dl+2M87MMq72gJv7w9m5e1vm/aa7C9IbVvYrOjZdrAKsRMPcuSV2ExzBmK/pzzl2lApSeWcSAfaj9iddECanB0X2d3Pmkkp4bPatEHQd6tkvahL8coqFvjFQ6Njoje/vhLyIcZcGY2dh411IYbu4xWp3FmIAQ+LW4VKke5hfzQGKM1y3ZhNa4nNjuV/2I1+tWqgHlpX4NNlsHBXdGkLdRAbo+zoFUJn76/8BY0n2b2Zmc5N/QJq6zTn9m7kiyvZ+SWUg7jkjEM3O3V1s5JsCsaX32kEEiuEQh8P/rXLi7V46JV3byFQxIzKIxNO4wL2PzDW7KTpLLwnE5NeGamrwSlhR01UAa8zEru7JacfiaO3yTs8Klr//NmOQjMTSGxHmXPY2jAIoVygNLp4i5/bDK1fcvM0Hfmo7/dPjH8j5qUVqoBk0OjWPdgc53jsP1yikEWLtVlgltEonrSlgrniyB6CK4c4AiayKzf7XteKanv874nPeOdDvq26rYpD3HHOq/ymVTJiSxFzeJ4OzsaG3un0eyujhN9pP3M6V57TVQ6+IFj4w5Dwm58leHh8fBYqxX9/DR4bGzL9hxT2K1fJS3VHZoV28nmdN87uimUZ1fwUO2fd8x+odDEBRhrl7BZw7o83BkeDUOH/g8RmLWz77UsrhCEIu9WMfoJuxUYkzBF1ZSNg2FddOVOroh6bPu5f8Sva6PJPHoob2UtQRtfUGVZ1PXbNEklbad+YFjVRXHSraPZEeHTxp5wWAS2hXrePBkK42SZ6pcOZRHnsEeqbBTABCQ41DnFmBY9aJ2obbIeHFQmSJuWagTWs7LOK2isceZSCwmmOPXZmrlUO7Wk++CrjE0tA/DgAIsJRsHk0NMCSwI9Rucbyn3gCsrGF0ONcKAv/g4crH5mZcSWhbp0BsfaRvYvXA8d48DYGpYkKZkRPcUcZe5g2ml5b0tTBx5wxVHQcz9LqHm5CJDKfIZD+4FJLC2X2jiiJAVuwWS/PaEa2ILopuZ9lw662Iq+r1/Ki6y7kr0PNifW13ZHt9NOWF9HTXDhVNU9Nb1VWttzzizh8NK/3Ns/2PGzzt1IfpZluhqjY+ggp2y0lJuDLLfh10VvVDkA5c7kOAZlizmrRu5wbDARadvKMHmSm8oEfnbVC0XwZgOvljKDc6U19E6XSsI6d3XEiervp4x4n4FMnWTtpkkZOrH5z7hSUpMyeAyPt8h2aOdgVTyo8ScpZDoLs8bosSqK9GV0sjFlq+viG54vPytdPRsGgReb0fETl13RJq5IkE5EGCecU/0e1ZdY4JAlQkw/9OM1YNOC0dwZX1Qu8rZEY9ykI8QOnC+nWDnBfihCGptqkcNkxPM1ta9P/GOSitjEyqb1H06ANCL1Fq9LWAk+3r36bzr1Wf9xFTj+MS6W0tTGpQyJHwDwhfQtsfaytZ7UFszrUcJtcEXsJTjFmJQnLFAqfBctqHKTw7FV8SJEh0SgVrUm9vjY4y88uHtBI8DbImsL4dt+pqch94fisVSBptaK9iekYAhkVthvj2wwXICzEkPsQJfpjH6pWmmjHUCXEJqk06GGl7HUbL50KsoQUggibuxlqUlmEyrjrSKFCEERhMQx1t+vmOfNP8bF6JR6rGlqHFu1ndvyeNITyWc0y91I+HbEz/PckEgRHtE/VPV90C1iRIuSM+RNV2ao+prcapsSwbGAV9xtxLOe8dts9MhvvNnJ384hfkyRvBmu6hF4atOYD7QdVguT7Qe12jU656LU7ef+44AXPddXaxVeidBK0FeG1mBFy3oeqaBBlo5UL+lA0HXVirlWCE1aHYM88jeTBgeBt1FJGnfQmtkUPEYYHtwpc00WWAsiSLABkEbIuYFkE4d7EGm/lTugrMESdGD3vccXzJUuWOQYdKl5Z1pFwq/WmqxH/4Qc78deqIc2noyohZ0NTXcwtk0vOsvgQI023Ni71XksyQpVJ8uB1GvKE/b9JNoCxisL9Jsvu04xj2a6l3FxTEk0315CdA6Ve3VlL8r0r8j2xk1EkXuLw+Los1cbb0RW55BnNmfluwZq2iVAuWw39aZYZi0f2DFI07PRGbPuObbXJ8uDUeqexpkzLK9eq0aOSxg6msbwMRJPp3WF9G5p8+h36SUNUmrvVjcw+GXX+yHTqoCFn5Lpupte2c3ZqOXCWd/S8/lWWGBq710UweHQRU9iOtwgMF76daUBPBukNhG"
                    }
                  ]
                }
              }
            ],
            "usage": {
              "prompt_tokens": 2579,
              "completion_tokens": 572,
              "total_tokens": 3151,
              "prompt_tokens_details": {
                "cached_tokens": 0
              },
              "completion_tokens_details": {
                "reasoning_tokens": 525,
                "image_tokens": 0
              }
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "whole exome sequencing",
          "tumorType": "Plexiform Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 2579,
          "output_tokens": 572,
          "total_tokens": 3151
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 1,
        "input": {
          "diagnosis": "Neurofibromatosis type 1 with optic pathway glioma",
          "assay": "Illumina whole exome sequencing ",
          "tumorType": "malignant triton tumor"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```",
          "model_id": "google/gemini-3-pro-preview",
          "usage": {
            "inputTokens": 2575,
            "outputTokens": 643,
            "totalTokens": 3218
          },
          "attempt": 1,
          "raw_response": {
            "id": "gen-1763583291-pQyux7ue6qgoJN8T6IHH",
            "provider": "Google AI Studio",
            "model": "google/gemini-3-pro-preview",
            "object": "chat.completion",
            "created": 1763583291,
            "choices": [
              {
                "logprobs": null,
                "finish_reason": "stop",
                "native_finish_reason": "STOP",
                "index": 0,
                "message": {
                  "role": "assistant",
                  "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```",
                  "refusal": null,
                  "reasoning": "**Mapping Diagnostic Concepts**\n\nI'm currently focused on mapping the user's diagnostic concept \"Neurofibromatosis type 1 with optic pathway\" to a suitable term within the target schema, which appears to be a controlled vocabulary. I'm exploring potential broader synonyms that encompass this diagnosis more comprehensively, ensuring accurate metadata. The controlled vocabulary adds some challenge, but I'm getting the hang of navigating it and finding appropriate options.\n\n\n**Schema Compatibility Assessment**\n\nI've successfully identified the appropriate mapping for the 'diagnosis' field, confirming that \"Neurofibromatosis type 1\" is the most accurate representation within the schema, directly corresponding to the provided input. I'm now cross-referencing against the 'assay' field values. Although there's a minor formatting issue with the provided input (trailing space), the core terms align; I'm confident in identifying the relevant option.\n\n\n**Validating Data Mappings**\n\nI've completed the validation of the output data against the schema's constraints. Both \"whole exome sequencing\" for the assay and \"Malignant Peripheral Nerve Sheath Tumor\" for tumor type have been confirmed to be valid entries within their respective enumerated lists. The entire JSON structure now aligns perfectly with the schema, and the mapping logic has successfully resolved the specific input values to the target schema terms.\n\n\n",
                  "reasoning_details": [
                    {
                      "format": "google-gemini-v1",
                      "index": 0,
                      "type": "reasoning.text",
                      "text": "**Mapping Diagnostic Concepts**\n\nI'm currently focused on mapping the user's diagnostic concept \"Neurofibromatosis type 1 with optic pathway\" to a suitable term within the target schema, which appears to be a controlled vocabulary. I'm exploring potential broader synonyms that encompass this diagnosis more comprehensively, ensuring accurate metadata. The controlled vocabulary adds some challenge, but I'm getting the hang of navigating it and finding appropriate options.\n\n\n**Schema Compatibility Assessment**\n\nI've successfully identified the appropriate mapping for the 'diagnosis' field, confirming that \"Neurofibromatosis type 1\" is the most accurate representation within the schema, directly corresponding to the provided input. I'm now cross-referencing against the 'assay' field values. Although there's a minor formatting issue with the provided input (trailing space), the core terms align; I'm confident in identifying the relevant option.\n\n\n**Validating Data Mappings**\n\nI've completed the validation of the output data against the schema's constraints. Both \"whole exome sequencing\" for the assay and \"Malignant Peripheral Nerve Sheath Tumor\" for tumor type have been confirmed to be valid entries within their respective enumerated lists. The entire JSON structure now aligns perfectly with the schema, and the mapping logic has successfully resolved the specific input values to the target schema terms.\n\n\n"
                    },
                    {
                      "format": "google-gemini-v1",
                      "index": 0,
                      "type": "reasoning.encrypted",
                      "data": "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"
                    }
                  ]
                }
              }
            ],
            "usage": {
              "prompt_tokens": 2575,
              "completion_tokens": 643,
              "total_tokens": 3218,
              "prompt_tokens_details": {
                "cached_tokens": 2027
              },
              "completion_tokens_details": {
                "reasoning_tokens": 594,
                "image_tokens": 0
              }
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "whole exome sequencing",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
        },
        "token_usage": {
          "input_tokens": 2575,
          "output_tokens": 643,
          "total_tokens": 3218
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 2,
        "input": {
          "diagnosis": "Watson Syndrome",
          "assay": "MGI whole genome sequencing",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole genome sequencing\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```",
          "model_id": "google/gemini-3-pro-preview",
          "usage": {
            "inputTokens": 2572,
            "outputTokens": 869,
            "totalTokens": 3441
          },
          "attempt": 1,
          "raw_response": {
            "id": "gen-1763583298-Kx439anA7LXAlBJ62tje",
            "provider": "Google AI Studio",
            "model": "google/gemini-3-pro-preview",
            "object": "chat.completion",
            "created": 1763583298,
            "choices": [
              {
                "logprobs": null,
                "finish_reason": "stop",
                "native_finish_reason": "STOP",
                "index": 0,
                "message": {
                  "role": "assistant",
                  "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole genome sequencing\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```",
                  "refusal": null,
                  "reasoning": "**Analyzing Schema Mappings**\n\nI'm currently focused on the mapping process. My task involves transforming specific terms like \"Watson Syndrome\" into more general, standardized diagnoses based on the target schema. I'm prioritizing accuracy in this crucial step, and I'm confident I can make it happen. I will work step by step, improving the output in the process.\n\n\n**Expanding Diagnosis Mapping**\n\nMy current focus is expanding the diagnosis mapping capabilities. I'm building on the previous work regarding \"Watson Syndrome\" and now considering more complex scenarios. I've realized the need to integrate broader medical knowledge into the mapping process to correctly address the nuanced nature of specific diagnoses. I'm exploring how to include contextual information to improve the accuracy of target schema selection, like \"Neurofibromatosis type 1\" given the Watson Syndrome input.\n\n\n**Identifying Sequencing Assays**\n\nI'm now zeroing in on sequencing assays. \"MGI whole genome sequencing\" clearly maps to \"whole genome sequencing\" in the schema.  I'm using this understanding to categorize specific instances into broader categories, ensuring my method accurately reflects the correct sequencing technique. This strategy ensures comprehensive and precise data categorization.\n\n\n**Refining Data Structures**\n\nMy primary objective now is to ensure the output data structure is precise and adheres to the established schema. I've focused on incorporating a new term into the output, \"Malignant Peripheral Nerve Sheath Tumor\", which requires updating the \"tumorType\" field. I've ensured this new data point correctly corresponds to the broader category defined in the schema. Further, I have confirmed that all field values align with the defined enums, and finally generated the JSON output.\n\n\n",
                  "reasoning_details": [
                    {
                      "format": "google-gemini-v1",
                      "index": 0,
                      "type": "reasoning.text",
                      "text": "**Analyzing Schema Mappings**\n\nI'm currently focused on the mapping process. My task involves transforming specific terms like \"Watson Syndrome\" into more general, standardized diagnoses based on the target schema. I'm prioritizing accuracy in this crucial step, and I'm confident I can make it happen. I will work step by step, improving the output in the process.\n\n\n**Expanding Diagnosis Mapping**\n\nMy current focus is expanding the diagnosis mapping capabilities. I'm building on the previous work regarding \"Watson Syndrome\" and now considering more complex scenarios. I've realized the need to integrate broader medical knowledge into the mapping process to correctly address the nuanced nature of specific diagnoses. I'm exploring how to include contextual information to improve the accuracy of target schema selection, like \"Neurofibromatosis type 1\" given the Watson Syndrome input.\n\n\n**Identifying Sequencing Assays**\n\nI'm now zeroing in on sequencing assays. \"MGI whole genome sequencing\" clearly maps to \"whole genome sequencing\" in the schema.  I'm using this understanding to categorize specific instances into broader categories, ensuring my method accurately reflects the correct sequencing technique. This strategy ensures comprehensive and precise data categorization.\n\n\n**Refining Data Structures**\n\nMy primary objective now is to ensure the output data structure is precise and adheres to the established schema. I've focused on incorporating a new term into the output, \"Malignant Peripheral Nerve Sheath Tumor\", which requires updating the \"tumorType\" field. I've ensured this new data point correctly corresponds to the broader category defined in the schema. Further, I have confirmed that all field values align with the defined enums, and finally generated the JSON output.\n\n\n"
                    },
                    {
                      "format": "google-gemini-v1",
                      "index": 0,
                      "type": "reasoning.encrypted",
                      "data": "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"
                    }
                  ]
                }
              }
            ],
            "usage": {
              "prompt_tokens": 2572,
              "completion_tokens": 869,
              "total_tokens": 3441,
              "prompt_tokens_details": {
                "cached_tokens": 2027
              },
              "completion_tokens_details": {
                "reasoning_tokens": 821,
                "image_tokens": 0
              }
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "whole genome sequencing",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
        },
        "token_usage": {
          "input_tokens": 2572,
          "output_tokens": 869,
          "total_tokens": 3441
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 3,
        "input": {
          "diagnosis": "neurofibromatosis, familial spinal",
          "assay": "open MRI",
          "tumorType": "unknown - no information available"
        },
        "response": {
          "success": true,
          "content": "Based on the provided Target Schema and the instructions to broaden narrow synonyms to standard controlled terms, here is the corrected metadata:\n\n```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"structural MRI\",\n  \"tumorType\": \"Unknown\"\n}\n```\n\n**Explanation of Corrections:**\n*   **diagnosis**: \"neurofibromatosis, familial spinal\" is a specific phenotype/variant of **Neurofibromatosis type 1** (caused by *NF1* mutations).\n*   **assay**: \"open MRI\" refers to the hardware configuration used to acquire Magnetic Resonance Imaging data. In the absence of functional or diffusion qualifiers, this is broadened to the standard term **structural MRI** (or \"conventional MRI\", though \"structural MRI\" is the preferred standard for anatomical imaging in this schema).\n*   **tumorType**: \"unknown - no information available\" is mapped to the exact enum value **Unknown**.",
          "model_id": "google/gemini-3-pro-preview",
          "usage": {
            "inputTokens": 2567,
            "outputTokens": 2246,
            "totalTokens": 4813
          },
          "attempt": 1,
          "raw_response": {
            "id": "gen-1763583307-aBclRJLhYVk2AcXhKoHl",
            "provider": "Google AI Studio",
            "model": "google/gemini-3-pro-preview",
            "object": "chat.completion",
            "created": 1763583307,
            "choices": [
              {
                "logprobs": null,
                "finish_reason": "stop",
                "native_finish_reason": "STOP",
                "index": 0,
                "message": {
                  "role": "assistant",
                  "content": "Based on the provided Target Schema and the instructions to broaden narrow synonyms to standard controlled terms, here is the corrected metadata:\n\n```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"structural MRI\",\n  \"tumorType\": \"Unknown\"\n}\n```\n\n**Explanation of Corrections:**\n*   **diagnosis**: \"neurofibromatosis, familial spinal\" is a specific phenotype/variant of **Neurofibromatosis type 1** (caused by *NF1* mutations).\n*   **assay**: \"open MRI\" refers to the hardware configuration used to acquire Magnetic Resonance Imaging data. In the absence of functional or diffusion qualifiers, this is broadened to the standard term **structural MRI** (or \"conventional MRI\", though \"structural MRI\" is the preferred standard for anatomical imaging in this schema).\n*   **tumorType**: \"unknown - no information available\" is mapped to the exact enum value **Unknown**.",
                  "refusal": null,
                  "reasoning": "**Mapping Terminology Correctly**\n\nI'm now focusing on mapping the input data to the target schema. The initial challenge is correctly interpreting the \"diagnosis,\" \"assay,\" and \"tumorType\" fields, especially with ambiguous values like \"unknown - no information available.\" I need to identify suitable broader synonyms for these, ensuring they align with the controlled terminology.\n\n\n**Refining Diagnosis Mapping**\n\nI'm digging deeper into the \"diagnosis\" field, particularly the \"neurofibromatosis, familial spinal\" entry. While it's historically linked to NF1, NF2, or Schwannomatosis, I'm leaning toward \"Neurofibromatosis type 1\" as the best broad fit, assuming no specific genetic information is provided. The key is finding the broadest, most accurate controlled term from the schema.\n\n\n**Confirming Diagnosis Term**\n\nI've circled back to the \"Familial spinal neurofibromatosis\" entry. After self-correction, I'm now certain \"Neurofibromatosis type 1\" is the proper broadest match. The clinical entity, FSNF, is caused by *NF1* mutations. Therefore, regardless of context, \"Neurofibromatosis type 1\" represents the most accurate controlled term from the schema.\n\n\n**Determining Assay Mapping**\n\nI'm now grappling with the assay type: \"open MRI.\" After reviewing the options\u2014conventional, structural, functional, diffusion, and angiography\u2014\"structural MRI\" emerges as the most precise broad match. It represents the anatomical imaging data produced. \"Conventional MRI\" is also a potential fit, but \"structural MRI\" is more aligned with established ontology preferences.\n\n\n**Confirming Assay Term**\n\nI've carefully considered the assay type, \"open MRI.\" While \"conventional MRI\" is viable, \"structural MRI\" is the better fit, aligning with metadata conventions. \"Structural MRI\" represents the anatomical imaging data, and the input explicitly described the use of this data. \"Unknown\" will be used for tumorType. It's a precise term to describe the lack of available data.\n\n\n**Confirming Assay And Diagnosis**\n\nI've finalized the assay mapping as \"structural MRI,\" recognizing its anatomical focus best reflects the data. \"Unknown\" will be used for \"tumorType.\" I've re-examined the \"diagnosis\" field and confirmed \"Neurofibromatosis type 1\" as the most accurate broad term for \"Familial spinal neurofibromatosis,\" considering the underlying genetic basis.\n\n\n**Verifying JSON Mapping**\n\nI've constructed a JSON output that includes the finalized mappings. I mapped the \"open MRI\" input to \"structural MRI\" and \"unknown - no information available\" to \"Unknown.\" After a final review, I confirmed that \"Neurofibromatosis type 1\" is the most accurate term for the diagnosis.\n\n\n**Concluding Mappings Precisely**\n\nThe \"structural MRI\" mapping for the assay feels optimal, aligning with metadata conventions. Although \"open MRI\" can technically include fMRI, its primary use is structural/anatomical imaging. \"Conventional MRI\" is an option but not optimal in this scenario. \"Structural MRI\" is the appropriate fit for the NF Data Portal schema. I've finalized the `assay` choice. With \"Neurofibromatosis type 1\" for `diagnosis`, and \"Unknown\" for `tumorType`, all look solid. The mappings are precise, and the JSON output is now complete.\n\n\n**Validating Final Output**\n\nMy final check confirms that \"Unknown\" is the ideal mapping for the `tumorType` field, perfectly representing the input \"unknown - no information available.\" The complete JSON structure, now fully validated, accurately reflects the agreed-upon mappings for all fields. I'm pleased with the accuracy of these mappings.\n\n\n",
                  "reasoning_details": [
                    {
                      "format": "google-gemini-v1",
                      "index": 0,
                      "type": "reasoning.text",
                      "text": "**Mapping Terminology Correctly**\n\nI'm now focusing on mapping the input data to the target schema. The initial challenge is correctly interpreting the \"diagnosis,\" \"assay,\" and \"tumorType\" fields, especially with ambiguous values like \"unknown - no information available.\" I need to identify suitable broader synonyms for these, ensuring they align with the controlled terminology.\n\n\n**Refining Diagnosis Mapping**\n\nI'm digging deeper into the \"diagnosis\" field, particularly the \"neurofibromatosis, familial spinal\" entry. While it's historically linked to NF1, NF2, or Schwannomatosis, I'm leaning toward \"Neurofibromatosis type 1\" as the best broad fit, assuming no specific genetic information is provided. The key is finding the broadest, most accurate controlled term from the schema.\n\n\n**Confirming Diagnosis Term**\n\nI've circled back to the \"Familial spinal neurofibromatosis\" entry. After self-correction, I'm now certain \"Neurofibromatosis type 1\" is the proper broadest match. The clinical entity, FSNF, is caused by *NF1* mutations. Therefore, regardless of context, \"Neurofibromatosis type 1\" represents the most accurate controlled term from the schema.\n\n\n**Determining Assay Mapping**\n\nI'm now grappling with the assay type: \"open MRI.\" After reviewing the options\u2014conventional, structural, functional, diffusion, and angiography\u2014\"structural MRI\" emerges as the most precise broad match. It represents the anatomical imaging data produced. \"Conventional MRI\" is also a potential fit, but \"structural MRI\" is more aligned with established ontology preferences.\n\n\n**Confirming Assay Term**\n\nI've carefully considered the assay type, \"open MRI.\" While \"conventional MRI\" is viable, \"structural MRI\" is the better fit, aligning with metadata conventions. \"Structural MRI\" represents the anatomical imaging data, and the input explicitly described the use of this data. \"Unknown\" will be used for tumorType. It's a precise term to describe the lack of available data.\n\n\n**Confirming Assay And Diagnosis**\n\nI've finalized the assay mapping as \"structural MRI,\" recognizing its anatomical focus best reflects the data. \"Unknown\" will be used for \"tumorType.\" I've re-examined the \"diagnosis\" field and confirmed \"Neurofibromatosis type 1\" as the most accurate broad term for \"Familial spinal neurofibromatosis,\" considering the underlying genetic basis.\n\n\n**Verifying JSON Mapping**\n\nI've constructed a JSON output that includes the finalized mappings. I mapped the \"open MRI\" input to \"structural MRI\" and \"unknown - no information available\" to \"Unknown.\" After a final review, I confirmed that \"Neurofibromatosis type 1\" is the most accurate term for the diagnosis.\n\n\n**Concluding Mappings Precisely**\n\nThe \"structural MRI\" mapping for the assay feels optimal, aligning with metadata conventions. Although \"open MRI\" can technically include fMRI, its primary use is structural/anatomical imaging. \"Conventional MRI\" is an option but not optimal in this scenario. \"Structural MRI\" is the appropriate fit for the NF Data Portal schema. I've finalized the `assay` choice. With \"Neurofibromatosis type 1\" for `diagnosis`, and \"Unknown\" for `tumorType`, all look solid. The mappings are precise, and the JSON output is now complete.\n\n\n**Validating Final Output**\n\nMy final check confirms that \"Unknown\" is the ideal mapping for the `tumorType` field, perfectly representing the input \"unknown - no information available.\" The complete JSON structure, now fully validated, accurately reflects the agreed-upon mappings for all fields. I'm pleased with the accuracy of these mappings.\n\n\n"
                    },
                    {
                      "format": "google-gemini-v1",
                      "index": 0,
                      "type": "reasoning.encrypted",
                      "data": "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"
                    }
                  ]
                }
              }
            ],
            "usage": {
              "prompt_tokens": 2567,
              "completion_tokens": 2246,
              "total_tokens": 4813,
              "prompt_tokens_details": {
                "cached_tokens": 2027
              },
              "completion_tokens_details": {
                "reasoning_tokens": 2046,
                "image_tokens": 0
              }
            }
          }
        },
        "score": 0.6666666666666666,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "conventional MRI",
          "tumorType": "Unknown"
        },
        "token_usage": {
          "input_tokens": 2567,
          "output_tokens": 2246,
          "total_tokens": 4813
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 4,
        "input": {
          "diagnosis": "Not Applicable",
          "assay": "immunohistochemistry of skin",
          "tumorType": "Cutaneous storiform neurofibroma"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Not Applicable\",\n  \"assay\": \"immunohistochemistry\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n```",
          "model_id": "google/gemini-3-pro-preview",
          "usage": {
            "inputTokens": 2567,
            "outputTokens": 481,
            "totalTokens": 3048
          },
          "attempt": 1,
          "raw_response": {
            "id": "gen-1763583328-9x1IGcdkjz99fc7IRKqk",
            "provider": "Google AI Studio",
            "model": "google/gemini-3-pro-preview",
            "object": "chat.completion",
            "created": 1763583328,
            "choices": [
              {
                "logprobs": null,
                "finish_reason": "stop",
                "native_finish_reason": "STOP",
                "index": 0,
                "message": {
                  "role": "assistant",
                  "content": "```json\n{\n  \"diagnosis\": \"Not Applicable\",\n  \"assay\": \"immunohistochemistry\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n```",
                  "refusal": null,
                  "reasoning": "**Considering Data Transformation**\n\nI'm currently focused on how to best transform this input data. My main thought is to expand \"immunohistochemistry of skin\" using a broader term from the target schema. \"Not Applicable\" and \"Cutaneous storiform neurofibroma\" seem fine, but I'm looking for a more generalized concept within the field to guide this transformation.\n\n\n**Revising Transformations**\n\nI've refined my approach to data transformation. For \"immunohistochemistry of skin,\" the shift to \"immunohistochemistry\" now seems correct, aligning with the schema's defined terms. Likewise, the initial \"Cutaneous storiform neurofibroma\" input will be mapped to \"Cutaneous Neurofibroma,\" avoiding unnecessary specificity. The \"Not Applicable\" entry remains unchanged.\n\n\n**Generating Final Output**\n\nI've completed the transformation process. The final JSON output is constructed, taking into account all previous refinements. Validation against the schema confirms the validity of \"Not Applicable,\" \"immunohistochemistry,\" and \"Cutaneous Neurofibroma,\" ensuring the final structure is consistent. This completes the output phase.\n\n\n",
                  "reasoning_details": [
                    {
                      "format": "google-gemini-v1",
                      "index": 0,
                      "type": "reasoning.text",
                      "text": "**Considering Data Transformation**\n\nI'm currently focused on how to best transform this input data. My main thought is to expand \"immunohistochemistry of skin\" using a broader term from the target schema. \"Not Applicable\" and \"Cutaneous storiform neurofibroma\" seem fine, but I'm looking for a more generalized concept within the field to guide this transformation.\n\n\n**Revising Transformations**\n\nI've refined my approach to data transformation. For \"immunohistochemistry of skin,\" the shift to \"immunohistochemistry\" now seems correct, aligning with the schema's defined terms. Likewise, the initial \"Cutaneous storiform neurofibroma\" input will be mapped to \"Cutaneous Neurofibroma,\" avoiding unnecessary specificity. The \"Not Applicable\" entry remains unchanged.\n\n\n**Generating Final Output**\n\nI've completed the transformation process. The final JSON output is constructed, taking into account all previous refinements. Validation against the schema confirms the validity of \"Not Applicable,\" \"immunohistochemistry,\" and \"Cutaneous Neurofibroma,\" ensuring the final structure is consistent. This completes the output phase.\n\n\n"
                    },
                    {
                      "format": "google-gemini-v1",
                      "index": 0,
                      "type": "reasoning.encrypted",
                      "data": "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"
                    }
                  ]
                }
              }
            ],
            "usage": {
              "prompt_tokens": 2567,
              "completion_tokens": 481,
              "total_tokens": 3048,
              "prompt_tokens_details": {
                "cached_tokens": 2027
              },
              "completion_tokens_details": {
                "reasoning_tokens": 441,
                "image_tokens": 0
              }
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Not Applicable",
          "assay": "immunohistochemistry",
          "tumorType": "Cutaneous Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 2567,
          "output_tokens": 481,
          "total_tokens": 3048
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 5,
        "input": {
          "diagnosis": "chromosome 17q11.2 deletion syndrome, 1.4Mb",
          "assay": "cell viability assay using Annexin V staining",
          "tumorType": "Pedunculated Cutaneous Neurofibroma"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"cell viability assay\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n```",
          "model_id": "google/gemini-3-pro-preview",
          "usage": {
            "inputTokens": 2586,
            "outputTokens": 887,
            "totalTokens": 3473
          },
          "attempt": 1,
          "raw_response": {
            "id": "gen-1763583333-iUGpxcOrIiaCDM2ol718",
            "provider": "Google AI Studio",
            "model": "google/gemini-3-pro-preview",
            "object": "chat.completion",
            "created": 1763583333,
            "choices": [
              {
                "logprobs": null,
                "finish_reason": "stop",
                "native_finish_reason": "STOP",
                "index": 0,
                "message": {
                  "role": "assistant",
                  "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"cell viability assay\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n```",
                  "refusal": null,
                  "reasoning": "**Mapping Vocabulary**\n\nI'm currently working on mapping the user's input data to a target schema. I'm focusing on broadening \"chromosome 17q11.2 deletion syndrome, 1.4Mb\" to a more general term within the controlled vocabulary. The assay term is straightforward and maps without adjustments. I need to consider how to capture the specific details of the deletion while still adhering to the target's broader scope.\n\n\n**Identifying Relationships Refined**\n\nI've successfully mapped the input `diagnosis` \"chromosome 17q11.2 deletion syndrome, 1.4Mb\" to \"Neurofibromatosis type 1\" in the target schema. After reviewing the context, this appeared to be the closest term. The assay \"cell viability assay using Annexin V staining\" seems to align directly. I'm focusing on the \"tumorType\" data, \"Pedunculated Cutaneous Neurofibroma,\" now.\n\n\n**Expanding Assay Focus**\n\nI've determined that the \"cell viability assay\" term is ideal for the target schema, effectively representing the broad assay type. While \"Annexin V\" is specific, the target prefers the wider category. I'm now honing in on the \"tumorType\" data, specifically mapping \"Pedunculated Cutaneous Neurofibroma\" to the appropriate term. I'm evaluating the available schema options in relation to the specificity of the input.\n\n\n**Verifying Schema Adherence**\n\nI've finalized the mapping to the target schema. \"Cutaneous Neurofibroma\" perfectly captures the critical details from \"Pedunculated Cutaneous Neurofibroma\" while respecting the schema's broader categorization. After validating each term (\"Neurofibromatosis type 1\", \"cell viability assay\", \"Cutaneous Neurofibroma\") against the enumerated list, I'm confident in the output's accuracy and adherence.\n\n\n",
                  "reasoning_details": [
                    {
                      "format": "google-gemini-v1",
                      "index": 0,
                      "type": "reasoning.text",
                      "text": "**Mapping Vocabulary**\n\nI'm currently working on mapping the user's input data to a target schema. I'm focusing on broadening \"chromosome 17q11.2 deletion syndrome, 1.4Mb\" to a more general term within the controlled vocabulary. The assay term is straightforward and maps without adjustments. I need to consider how to capture the specific details of the deletion while still adhering to the target's broader scope.\n\n\n**Identifying Relationships Refined**\n\nI've successfully mapped the input `diagnosis` \"chromosome 17q11.2 deletion syndrome, 1.4Mb\" to \"Neurofibromatosis type 1\" in the target schema. After reviewing the context, this appeared to be the closest term. The assay \"cell viability assay using Annexin V staining\" seems to align directly. I'm focusing on the \"tumorType\" data, \"Pedunculated Cutaneous Neurofibroma,\" now.\n\n\n**Expanding Assay Focus**\n\nI've determined that the \"cell viability assay\" term is ideal for the target schema, effectively representing the broad assay type. While \"Annexin V\" is specific, the target prefers the wider category. I'm now honing in on the \"tumorType\" data, specifically mapping \"Pedunculated Cutaneous Neurofibroma\" to the appropriate term. I'm evaluating the available schema options in relation to the specificity of the input.\n\n\n**Verifying Schema Adherence**\n\nI've finalized the mapping to the target schema. \"Cutaneous Neurofibroma\" perfectly captures the critical details from \"Pedunculated Cutaneous Neurofibroma\" while respecting the schema's broader categorization. After validating each term (\"Neurofibromatosis type 1\", \"cell viability assay\", \"Cutaneous Neurofibroma\") against the enumerated list, I'm confident in the output's accuracy and adherence.\n\n\n"
                    },
                    {
                      "format": "google-gemini-v1",
                      "index": 0,
                      "type": "reasoning.encrypted",
                      "data": "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"
                    }
                  ]
                }
              }
            ],
            "usage": {
              "prompt_tokens": 2586,
              "completion_tokens": 887,
              "total_tokens": 3473,
              "prompt_tokens_details": {
                "cached_tokens": 2027
              },
              "completion_tokens_details": {
                "reasoning_tokens": 842,
                "image_tokens": 0
              }
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "cell viability assay",
          "tumorType": "Cutaneous Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 2586,
          "output_tokens": 887,
          "total_tokens": 3473
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 6,
        "input": {
          "diagnosis": "Neurofibromatosis type 1 with scoliosis",
          "assay": "anti-tag immunocytochemistry",
          "tumorType": "sessile cutaneous neurofibroma"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"immunocytochemistry\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n```",
          "model_id": "google/gemini-3-pro-preview",
          "usage": {
            "inputTokens": 2575,
            "outputTokens": 525,
            "totalTokens": 3100
          },
          "attempt": 1,
          "raw_response": {
            "id": "gen-1763583342-gou1RThgBPeObcBJ8Qri",
            "provider": "Google AI Studio",
            "model": "google/gemini-3-pro-preview",
            "object": "chat.completion",
            "created": 1763583342,
            "choices": [
              {
                "logprobs": null,
                "finish_reason": "stop",
                "native_finish_reason": "STOP",
                "index": 0,
                "message": {
                  "role": "assistant",
                  "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"immunocytochemistry\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n```",
                  "refusal": null,
                  "reasoning": "**Mapping Terminology**\n\nI'm currently focused on mapping the input \"Neurofibromatosis type 1 with scoliosis\" to the Target Schema's controlled vocabulary. I need to identify the closest broader term from the Target Schema that accurately reflects this diagnosis. The challenge lies in ensuring that the selected term captures both the neurofibromatosis and the scoliosis components without losing critical diagnostic information. I'm exploring potential mappings that preserve the specificity of the diagnosis.\n\n\n**Identifying Key Concepts**\n\nMy focus has shifted to the `assay` and `tumorType` fields. I've determined that \"anti-tag immunocytochemistry\" falls under the broader category of \"immunocytochemistry\" within the target schema. Similarly, \"sessile cutaneous neurofibroma\" maps to the more general \"Cutaneous Neurofibroma\". I'm now integrating these findings to formulate a comprehensive output.\n\n\n**Consolidating Findings**\n\nI've verified that all the required elements, \"Neurofibromatosis type 1\", \"immunocytochemistry\", and \"Cutaneous Neurofibroma,\" are present within their designated enumerations. This confirmation allows me to proceed with confidence in finalizing the JSON output. I'm now ready to generate the final structured representation of the data.\n\n\n",
                  "reasoning_details": [
                    {
                      "format": "google-gemini-v1",
                      "index": 0,
                      "type": "reasoning.text",
                      "text": "**Mapping Terminology**\n\nI'm currently focused on mapping the input \"Neurofibromatosis type 1 with scoliosis\" to the Target Schema's controlled vocabulary. I need to identify the closest broader term from the Target Schema that accurately reflects this diagnosis. The challenge lies in ensuring that the selected term captures both the neurofibromatosis and the scoliosis components without losing critical diagnostic information. I'm exploring potential mappings that preserve the specificity of the diagnosis.\n\n\n**Identifying Key Concepts**\n\nMy focus has shifted to the `assay` and `tumorType` fields. I've determined that \"anti-tag immunocytochemistry\" falls under the broader category of \"immunocytochemistry\" within the target schema. Similarly, \"sessile cutaneous neurofibroma\" maps to the more general \"Cutaneous Neurofibroma\". I'm now integrating these findings to formulate a comprehensive output.\n\n\n**Consolidating Findings**\n\nI've verified that all the required elements, \"Neurofibromatosis type 1\", \"immunocytochemistry\", and \"Cutaneous Neurofibroma,\" are present within their designated enumerations. This confirmation allows me to proceed with confidence in finalizing the JSON output. I'm now ready to generate the final structured representation of the data.\n\n\n"
                    },
                    {
                      "format": "google-gemini-v1",
                      "index": 0,
                      "type": "reasoning.encrypted",
                      "data": "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"
                    }
                  ]
                }
              }
            ],
            "usage": {
              "prompt_tokens": 2575,
              "completion_tokens": 525,
              "total_tokens": 3100,
              "prompt_tokens_details": {
                "cached_tokens": 2027
              },
              "completion_tokens_details": {
                "reasoning_tokens": 480,
                "image_tokens": 0
              }
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "immunocytochemistry",
          "tumorType": "Cutaneous Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 2575,
          "output_tokens": 525,
          "total_tokens": 3100
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 7,
        "input": {
          "diagnosis": "neurofibromatosis, peripheral type",
          "assay": "wide bore MRI",
          "tumorType": "no clear diagnosis"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"conventional MRI\",\n  \"tumorType\": \"Unknown\"\n}\n```",
          "model_id": "google/gemini-3-pro-preview",
          "usage": {
            "inputTokens": 2566,
            "outputTokens": 1367,
            "totalTokens": 3933
          },
          "attempt": 1,
          "raw_response": {
            "id": "gen-1763583349-dcoJqHdmRIoehr4ejmoR",
            "provider": "Google AI Studio",
            "model": "google/gemini-3-pro-preview",
            "object": "chat.completion",
            "created": 1763583349,
            "choices": [
              {
                "logprobs": null,
                "finish_reason": "stop",
                "native_finish_reason": "STOP",
                "index": 0,
                "message": {
                  "role": "assistant",
                  "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"conventional MRI\",\n  \"tumorType\": \"Unknown\"\n}\n```",
                  "refusal": null,
                  "reasoning": "**Analyzing Synonym Mapping**\n\nI'm currently focused on the synonym mapping process. Right now, I'm examining ways to broaden these narrow terms and align them with the target schema. Specifically, I'm analyzing the relationships between \"neurofibromatosis, peripheral type\" and its potential broader equivalents. I'm also considering how \"wide bore MRI\" could be mapped to a more standard term, as well as addressing the ambiguity in \"no clear diagnosis.\"\n\n\n**Defining Broader Equivalents**\n\nI've been drilling down on identifying the best broader equivalents for specific terms. For \"neurofibromatosis, peripheral type,\" I'm now certain \"Neurofibromatosis type 1\" is the most accurate schema match. Regarding \"wide bore MRI,\" I'm leaning toward \"conventional MRI\" unless further context emerges. I'm also still working through the \"no clear diagnosis\" problem.\n\n\n**Evaluating MRI Equivalents**\n\nI'm now zeroing in on the \"wide bore MRI\" dilemma. I've concluded \"conventional MRI\" is the best broad term given its general use for standard sequences. The alternative, \"structural MRI,\" is also valid, but \"conventional MRI\" feels more inclusive given \"wide bore\" primarily relates to the machine type. I'm now exploring other relevant aspects of the input.\n\n\n**Reconciling Diagnostic Uncertainty**\n\nI've been wrestling with the \"no clear diagnosis\" input for the `tumorType` field. After further reflection, I'm confident \"Unknown\" is the most accurate mapping, given the implication that a diagnostic attempt was made. While \"Not Applicable\" can apply in the absence of a tumor, the presence of \"no clear diagnosis\" suggests a tumor might be present, but the type isn't known.  This aligns best with \"Unknown\", the standard mapping.\n\n\n**Validating Final Outputs**\n\nI've finalized my thinking on the tumor type and am convinced that \"Unknown\" is the correct mapping for \"no clear diagnosis.\" With this in mind, I've re-evaluated \"assay.\" While \"structural MRI\" is a valid alternative, \"conventional MRI\" better reflects the standard imaging procedure implied by \"wide bore MRI.\" I'm also now certain \"Neurofibromatosis type 1\" is the most accurate schema match for \"neurofibromatosis, peripheral type.\" These are the mappings I will now use.\n\n\n**Refining Schema Alignment**\n\nMy focus is now on the mapping of \"conventional MRI\" and \"Unknown\" to the schema fields. I've confirmed \"conventional MRI\" as the most appropriate general term for \"wide bore MRI,\" given its focus on standard anatomical scanning. I'm also satisfied that \"Unknown\" is the best fit for \"no clear diagnosis\" in the tumorType field, as it accurately reflects the diagnostic ambiguity. My current mapping choices are aligned to schema terms and look good.\n\n\n",
                  "reasoning_details": [
                    {
                      "format": "google-gemini-v1",
                      "index": 0,
                      "type": "reasoning.text",
                      "text": "**Analyzing Synonym Mapping**\n\nI'm currently focused on the synonym mapping process. Right now, I'm examining ways to broaden these narrow terms and align them with the target schema. Specifically, I'm analyzing the relationships between \"neurofibromatosis, peripheral type\" and its potential broader equivalents. I'm also considering how \"wide bore MRI\" could be mapped to a more standard term, as well as addressing the ambiguity in \"no clear diagnosis.\"\n\n\n**Defining Broader Equivalents**\n\nI've been drilling down on identifying the best broader equivalents for specific terms. For \"neurofibromatosis, peripheral type,\" I'm now certain \"Neurofibromatosis type 1\" is the most accurate schema match. Regarding \"wide bore MRI,\" I'm leaning toward \"conventional MRI\" unless further context emerges. I'm also still working through the \"no clear diagnosis\" problem.\n\n\n**Evaluating MRI Equivalents**\n\nI'm now zeroing in on the \"wide bore MRI\" dilemma. I've concluded \"conventional MRI\" is the best broad term given its general use for standard sequences. The alternative, \"structural MRI,\" is also valid, but \"conventional MRI\" feels more inclusive given \"wide bore\" primarily relates to the machine type. I'm now exploring other relevant aspects of the input.\n\n\n**Reconciling Diagnostic Uncertainty**\n\nI've been wrestling with the \"no clear diagnosis\" input for the `tumorType` field. After further reflection, I'm confident \"Unknown\" is the most accurate mapping, given the implication that a diagnostic attempt was made. While \"Not Applicable\" can apply in the absence of a tumor, the presence of \"no clear diagnosis\" suggests a tumor might be present, but the type isn't known.  This aligns best with \"Unknown\", the standard mapping.\n\n\n**Validating Final Outputs**\n\nI've finalized my thinking on the tumor type and am convinced that \"Unknown\" is the correct mapping for \"no clear diagnosis.\" With this in mind, I've re-evaluated \"assay.\" While \"structural MRI\" is a valid alternative, \"conventional MRI\" better reflects the standard imaging procedure implied by \"wide bore MRI.\" I'm also now certain \"Neurofibromatosis type 1\" is the most accurate schema match for \"neurofibromatosis, peripheral type.\" These are the mappings I will now use.\n\n\n**Refining Schema Alignment**\n\nMy focus is now on the mapping of \"conventional MRI\" and \"Unknown\" to the schema fields. I've confirmed \"conventional MRI\" as the most appropriate general term for \"wide bore MRI,\" given its focus on standard anatomical scanning. I'm also satisfied that \"Unknown\" is the best fit for \"no clear diagnosis\" in the tumorType field, as it accurately reflects the diagnostic ambiguity. My current mapping choices are aligned to schema terms and look good.\n\n\n"
                    },
                    {
                      "format": "google-gemini-v1",
                      "index": 0,
                      "type": "reasoning.encrypted",
                      "data": "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"
                    }
                  ]
                }
              }
            ],
            "usage": {
              "prompt_tokens": 2566,
              "completion_tokens": 1367,
              "total_tokens": 3933,
              "prompt_tokens_details": {
                "cached_tokens": 2027
              },
              "completion_tokens_details": {
                "reasoning_tokens": 1327,
                "image_tokens": 0
              }
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "conventional MRI",
          "tumorType": "Unknown"
        },
        "token_usage": {
          "input_tokens": 2566,
          "output_tokens": 1367,
          "total_tokens": 3933
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 8,
        "input": {
          "diagnosis": "acoustic neurofibromatosis",
          "assay": "RNA-seq with ribosomal RNA depletion",
          "tumorType": "Acoustic neuroma of left vestibular nerve"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"NF2-related schwannomatosis\",\n  \"assay\": \"RNA-seq\",\n  \"tumorType\": \"Schwannoma\"\n}\n```",
          "model_id": "google/gemini-3-pro-preview",
          "usage": {
            "inputTokens": 2574,
            "outputTokens": 1124,
            "totalTokens": 3698
          },
          "attempt": 1,
          "raw_response": {
            "id": "gen-1763583362-3cXNfnOBLLMpszxvxWjK",
            "provider": "Google AI Studio",
            "model": "google/gemini-3-pro-preview",
            "object": "chat.completion",
            "created": 1763583362,
            "choices": [
              {
                "logprobs": null,
                "finish_reason": "stop",
                "native_finish_reason": "STOP",
                "index": 0,
                "message": {
                  "role": "assistant",
                  "content": "```json\n{\n  \"diagnosis\": \"NF2-related schwannomatosis\",\n  \"assay\": \"RNA-seq\",\n  \"tumorType\": \"Schwannoma\"\n}\n```",
                  "refusal": null,
                  "reasoning": "**Mapping Terminology Concepts**\n\nI'm currently focused on mapping the user's input data to the target schema. Expanding \"acoustic neurofibromatosis\" to its broader concept and aligning \"RNA-seq with ribosomal RNA depletion\" to a standard assay are top priorities. I'm exploring various algorithms for this terminology matching.\n\n\n**Defining Tumour Specificity**\n\nI've just added \"neuroma of left vestibular nerve\" to my analysis. The challenge lies in accurately defining its `tumorType`. I am carefully reviewing the ontology to ensure a precise classification that corresponds to the target schema.\n\n\n**Resolving Tumor Nomenclature**\n\nI'm now zeroing in on \"Acoustic neuroma of left vestibular nerve.\" I found a nuance in the target schema: while \"Vestibular Schwannoma\" exists in `diagnosis`, the `tumorType` enum lists \"Schwannoma.\" I'm broadening \"Acoustic neuroma\" to \"Schwannoma\" for accurate mapping. My current focus is aligning these synonyms correctly.\n\n\n**Formulating Final Mapping**\n\nI've finalized the data mapping based on the target schema. \"Acoustic neurofibromatosis\" now translates to \"NF2-related schwannomatosis.\" I've confirmed that \"RNA-seq with ribosomal RNA depletion\" aligns with \"RNA-seq,\" and \"Acoustic neuroma\" correctly maps to \"Schwannoma.\" The output structure is now complete, ensuring a precise and standardized representation of the data as shown in the updated JSON structure.\n\n\n**Refining Term Mapping**\n\nI'm verifying that \"NF2-related schwannomatosis\" is the precise term, having confirmed \"fibromatosis type 2\" isn't present. Also, \"RNA-seq\" is confirmed in the `assay` enum, and \"Schwannoma\" is present as expected within `tumorType`. The mapping logic is solid, ensuring correct term alignment.\n\n\n",
                  "reasoning_details": [
                    {
                      "format": "google-gemini-v1",
                      "index": 0,
                      "type": "reasoning.text",
                      "text": "**Mapping Terminology Concepts**\n\nI'm currently focused on mapping the user's input data to the target schema. Expanding \"acoustic neurofibromatosis\" to its broader concept and aligning \"RNA-seq with ribosomal RNA depletion\" to a standard assay are top priorities. I'm exploring various algorithms for this terminology matching.\n\n\n**Defining Tumour Specificity**\n\nI've just added \"neuroma of left vestibular nerve\" to my analysis. The challenge lies in accurately defining its `tumorType`. I am carefully reviewing the ontology to ensure a precise classification that corresponds to the target schema.\n\n\n**Resolving Tumor Nomenclature**\n\nI'm now zeroing in on \"Acoustic neuroma of left vestibular nerve.\" I found a nuance in the target schema: while \"Vestibular Schwannoma\" exists in `diagnosis`, the `tumorType` enum lists \"Schwannoma.\" I'm broadening \"Acoustic neuroma\" to \"Schwannoma\" for accurate mapping. My current focus is aligning these synonyms correctly.\n\n\n**Formulating Final Mapping**\n\nI've finalized the data mapping based on the target schema. \"Acoustic neurofibromatosis\" now translates to \"NF2-related schwannomatosis.\" I've confirmed that \"RNA-seq with ribosomal RNA depletion\" aligns with \"RNA-seq,\" and \"Acoustic neuroma\" correctly maps to \"Schwannoma.\" The output structure is now complete, ensuring a precise and standardized representation of the data as shown in the updated JSON structure.\n\n\n**Refining Term Mapping**\n\nI'm verifying that \"NF2-related schwannomatosis\" is the precise term, having confirmed \"fibromatosis type 2\" isn't present. Also, \"RNA-seq\" is confirmed in the `assay` enum, and \"Schwannoma\" is present as expected within `tumorType`. The mapping logic is solid, ensuring correct term alignment.\n\n\n"
                    },
                    {
                      "format": "google-gemini-v1",
                      "index": 0,
                      "type": "reasoning.encrypted",
                      "data": "EqsiCqgiAdHtim9Mw1l+rvsyeXyR2lnpbg+uInI9AXLJ/Zb1iMAPNDIztj49iaZyvLBFOj8mk6/3q5ucxkHT1LTv+1gcE+S+PO3lOaxavHU5fFW07nfLcldg2mqASX4izir9qJf2xdmKeRLk930IeOfNoQFH9cL6SMj9t1PvhXNMtWWXWgvQu7Qau+emyzMf/pNsUahsa+0+Xm/J4j605cO1s7cDcKRu/8p7VtXmE2NVulWD3BYUqvHhAknbVnBcO0EL7NMrNoHxLTJ91gLo/iMjkfbQy5zhdWkDUDVs6HXS0shtsdOAr8/FBQnunPkx9fxdwA76NEQeNOT4xe3VmQfL003EwMWwJCocD1/cBV9+m6XEqLvLZqEvT7CWjs3x+r6/twWlRj+mh3tooUQDXa7LTQ3r5dXLb+W361bioNYlHIGjiuyShb2VOrB/3DoZ3v6A3v3Hmvossv4FJSDtk+pLFOb6d+SQax2BDOTrhBNnQkk+hKp+GF9qRUKYCQkEnqwmgnQD3hxrLDR2ydoJGsCaqEkPREnf9auqyv5pwRDQWym5sUL9OCI+ICxhbZdYHHVovQKOVsaTjt/B2dkzE95T+Y6Ur1OqcCYF7Rndt33X39tzuJX9C7vb0kskwDrW7cRx4s2xNGOe5FyQkGqO7GAMcq+7cCUGD1ZQmTOjfPCdm8i1PSJzT5a6IkWY+Q6MLzZ9iOVfcpsMJbJn/FPQLgXHJJJMKmDcdhT2mmBQh3o1SUJ/dbKiWAtw+pWFm6RuaTZgafszpBkRlmzmbzG3SrS/wgzCakA9/ERp403e+uoERPJBo1RqPg6WB1RQuanL/FagxGImUWy4fQrWzlUdkCB/SyINchNIMW9VomrUHC26lXp0RHID2CGgJytYw+AjFwAxMz5F99TiyiJ5Y3g5AK4u9PtsoFwnU7J0re5QUKm817bnq0/fP4msc4KTHDinl24JQBU7Mn0NJFgsLvPJeMz6TgXI9FkuNrPqK2LfZ2fKw3LcwrQebMNOXitVO3Y2Yaa8/rizZSuHY+gi8abxo0hfvYyoNOg6zAaBJveuN88s8jdEKX3rG2Ibn5tYc4fjrZvi+znQ1Y1GBv3MaLaasMtNrFWfqI8kiZQS+y1xXBCPe1ANdrg6k8jsnMzAQD8HEHdKy9X+zWrlkSUywIa1+DzPCnqQlZc9IjDV7QaEQgGt76GZnebUzeFXSt1IGQFUuQ3m/35wi0xrLgUjO2jPPsf0vuErF/axudhL9sz75g8BbDRN8NBZcXhv4CjAgmOLFRzAoO41XPnk23pBCQXT/fAmoeL+VwqogmNBwrDEXzIp/keFdE8GICZYFpjD+K4NjcF7E9oLljsqP2G+u6rEByHyfLv2XaP2Oj0fPAqpgBa1hfio60KAjZc0bP0TuOQPkqPShcrVrmEKw5jrzSn/sCAH9rePr9LmrwciUWK0ahzBWjMrKopkkvJIaSfPv12ymAu6U3VODs20HROGEl86T8iIapqMOntprEgEvXPoZ9IjuW0yAo/i3oqND015FlauzKvZVbkKyt134nBsdebdC0VhFfLp4SpPXudFNYg85MIiB8os+39AMThWxZ44yRWKQsKBPwrihwSg1m0iAfxFPneqKGbgld9Lu7K3FTJD/ZP44BGIXzHb36KmOhhRQF+rXKA2HqO3d3AyRAeiC2aF83RPAmV7pUGrjc3+UfZcqjXMwxs0ySA3KzMA/Ms2MJbK0vXy/q4XRT7Aks4Yi7lo6hHdXEE1hOcOWWNk58VnZ4edGyb8ya38sjTBgMBdj9Qoc/imczaovLKJE6N7JEmtsqhzkIfnwPsOtYXZE08LlNNEccnS5uHk20O/wXXsVK5OVfgrcyXjwjXCXnEeZuD5Gi/F/F91tZl8giU0t/ar+WLky2dMBIGX8atvASEbrpeNfQGMWHi3wtLjYdy08q/Fht7gvEraDFH5j62B6esbqoHCgvvMdBPhlcf80WGTtpE4lxxCkDp0AFYA02kKfOp4ZSgbL3rojVi7cV08zo72rHSO0sF7U/nE6UcEdUKDUjLEL2oxp3PfJohYS+o+dLTJTQsWdDk9+IiinaHw9FTvflxAK/NKpy74m+x1yL55NiqKj2IjvFod+lr7pcy8w4K5DPgPjvJD35Ao0GMZpzBjec8DvT5LSohIdJlsmNXWCR+5nRxJI0Sw/BR49mLWhOC577jN9EOO/0ufiVpSWPQLpd06zXkItYDP67mKKnZO+LXxrKaBMH6NiwWH6CzGbg8sU2aNdpNwThdgtrI/4wQmrdhtQVB6+5p4TkKqd+lRjjl9v7XbrYoILg7gyOhw3uhXD6pyR/I9CHpRLqbqHKUkFWk4faNYsjt7MlVvbwNmoRM5C3KBpglSa/n78JpJYmUUy20/9OdodHqJSxXxUI+jpLFkzhoa8aulWGL2k4u5sDdszCYT5CEktlUY80fVcU5ZQZv+xlYubNsEzc0AppNF3NfqVMUIvMjDjhUQzNIz5ocfKqY5czzHjYBy3A+sl5g50JVe1Sj9DcZwMf0pqIw+djXLX7G6jvBQr1XjmQmdWY/fE3KWmq0RjkovoQ27c/B7jcxoQQL+A6j3DDIqfU9Lw85J4fj+I2MtxaTDqgcdbm1J9KjENXXhuOe4xFjlCw9Yt2FRVQJ1JTunjAMqYxZUCO3mZ6dUqF1KYGQHQ69jBNjpGC9NIAgyYA1UxR9joJmlOsm0EccpE8wvQMhGbBa6L2O5cp2fVKWGMRp2tx1INFM2ATrgGfDguciHi5CdIXeFhYhfg5AEDBkkv6dtl4UstCtMOP534dVR0/XZCYRgRTPztLkBIh5AUM+7k3h7pjF7B9V0vnD7j8kbyCrLA+Qga3onnK0j/rbZiajQVjMvx4R+CsFT874iBZMOoNwuljwxoOxanId27pZUmBCh8KH+5ZqDzC6GQ9k8h/c3Jh9uW1xtd9VIweUcsoaVxAtenShtOeKHJn/ZqQ56C0HD8qshmwIjNjBVmSz14ztPsRBm4OvPmv0Imhl4SVh9pFvKTbVTJE7ZJW5jECg30tfAywiXHEwO1QizWKlmYsMsVID2kH8PPCFQeOIR6hS8EuKHfUhpkUuHBOEfaaAvpVrA5HhAOZ1m+HbsGEnPCfoxr6d9Jkl0FKee84KqMyN/GLB79Py/utF3/f4dh210Ka8ghFfJ3BH4J47rkqTuzSU1Ji6zqGOg7ZgXtnqe/4m/Bsc05w0PzwRPirbXQ+LXBLuDKTSK+Bb+PYF1dB22sW7L6q+V29z3kEGlzQL8SjDcYOcBMPJWhm55ypYqsOnfReDMxSdPAxUrbVm7pL0Lxyu9EbAayHNiTLZveFohE9SLB5Y8RrAeG/Z7J28PR8YNrL81VKTRWP3T21p1hyK9I6qaKUBfuLiaCobi+AVpFm9kKiLK3t/u+oORDKxsyXzPP5nNZQh0kN2ARC2Y2mdQnswou7srgGm14t8F44jIhKlpfGa2yPoBdLqC42Kd3LcE5KBGi6GSdaYetkKOgLO5VtQcsSJNZMvSVfOY9M/C+DTvjvXpapArv6W4Sqe7z4wD7LDkCUDj9Grymqp/53ztz5mtk5PPh6SI871IS/DMYPFUmgrDx1uwqnqAA7tTOwuoeMGbMZirHiaKZVkAocL5vw2vv6jO17wTaoffPPdvYBGKeU4w0lsVDApiJT6hV2F1mHx/LXsXx7TeSgl6dT7wPRPSCSuUR5PAX29Rj201Ip/7GgRboBzpbER4o8MD9wel//HsghCTSPx1j9bzX+E9h9W3MP75SL+CIoOQs0Oeh0YuwqBF6otxTYlZa3E3auElBaNckRFKdLQrrO/JL4+0B1rIafLs3M6Unizkg2ZR2fsU0rxR+tXPJsF0xNDTEq/V3BB4pZiYJ3Q060Y3lYNN5NR6HPoAoBf+ZpJjQhJ0z53ZfwYLdPq498iqPlkd9A7tisQroz0tRwg5J9HatzAHGx6GT5qRivi/751GCAtNABJTtDFqUpsTUpOTbdNTtXYWLFS/CWMUCdhLzu35Q/Pf/CIRxE4tXj+ayUtUgybzQLg9J7qqmGmUBRUYS/ovBOc/N+C49b4gLRaIWI869xiZrOXFTYgEE53SF9cEQEggYYydBuqLL+msYdjRI/SOdLJu+uHIwtGBkuj+z0MUmWsxetEOF8oek/L5nUpc6aUVkU+yTn+fURuoJR7i3fw7Nkn3nULXsmGM5ilpxpwfVtv7rXgApuXaw+qjhtImjqxpQ5mQIHbAUrNsuxh9gQQfEl2V1V3xjt66inlrBpi5YkMozV2DAZIZWuTe1PB6+IWtQdGqaCbcqWlQrYThlZm81er/v+XFLC0FsijMDhIuJDrRn8Mv+aHWA8PoWxEZX+OqCOd6VUqDNbGdIKwd/28Yxu7qEuRlCExe+YZkgwpIygmddT6yTFOPcgGIL0J3b+qN9KES9jcJlaS3jzxnvgvQvDrwJqxUsH4grhisHP+3oqgfoWe4zTCYKF/74bPtOV7qfY4HvMIVByTPeEnC8swUj3WBU3AQqf4QFozPiTRxpGdbKV3Gf9VfiTsGwLRLeWXbGs9X40+5oTa099lbbIkc/FISP+wnYTqAGl4GpRjik6qtwVz0aQEfuk82y8TQxXVDbALv8md//H0BtrfsECzpm+hF8iYhOg8qAjsquiKvAQvg5z5yhRHaS+hxRSOAh8t4EfJsXyH2IdYz7BWxvmOsurjaWxwrKg2g55DQI7IDAY9mT6GDMAwbdCaUDPON5wdtTPHFxTVNVmwExzsfWQZbMwOqvl2Wauwua6QRCNB+pBpn4f+NBXlm64rytJIihoplipB4xQQ0yJZ1X81Yphc5YxogMBZ/TMrqrDd7RBIgWILtB0kK5IO/iS0YsxPqAgLXkqRbcpMGPubjYyEPykpuxaYGzzumvUje2mRSyCSQFPGJLXe9ZPSGODY4k/pAGwzXUpHRncvctLgMEsdXds66wrw8GYaQu5N+vdBLAFtjUq7FYUQJOTdlgCVxZE5NcV7EiQv4vXv6MEpt8fAL1Se9XH1UbV3croA5DgDgLnBDIkpAG4AWlXHusd6WSNXWyvhl4YkR26PZfWr88JLQb1NGc89GveEQob1rE6DH0//NwSJmODET141TTTq+gCWrP0NOP17fuQEujvEV1dJepZGIxrU1Dpor9uKlhKdOsfhidoIEtYQYXiFNBDLMHwgPuDOf1JWEx4RiUTT4e/yR7itNOVju7dAyC0ITYjlooIqTLnpYotuyaIZMea/smZgUSJoIevsU7pPDdOGc5Thzu79M6syRYlHQLn7cMMWrki9nBIRuS9C7h0idy5uwa5lETQJzgpff+d2zV/MUxL0cg4oSoj4zgmgeg+IV0ysLWdUrGNvPdw/+SmclW9h6SkKjd8sCrUrPNgb0mDCDsH44aXC9gdsPy6uAwqtFrWuv14q5gwMuMKdJlENtsWALyJcIAU1fob/XVa20Jg2VxWAnT33/1YrywNr9vgQ5b0z2Q1njU4MfmfrQRmPc7BmwHhrXhfaV8v6zX1p2HHX6VNwpZ3G3zcrXNQjxX1u0BVFfXsEixd3tXlPpELqFOnE5pAzfMrlLJT6yvTXG2BqCMtmvXSMKF1HVFbCgu3STfLPGk3aXq7rTNDnS1zfgsLhZaLB+jnh2LZon682xFS5PZTkEOewFunTccFAZKZ6K99Ju3DOxJau5GjUXSH2pYfuuZD3LsDVaYn1Sn3fZVQwkpYzROfVhBHJ9r1milPaMibpPDyVwSyp/xPm+R3FEPXQrCoAwAGMKHl/R5MpOYokJlaGIoZYJ0oE9LLu9fp/GYPu1vjb6y6a/MrRz3gHdrhQau2ofpks/xxwP8CxWIddwkMUJ4JWZeu4YtKD61Uow"
                    }
                  ]
                }
              }
            ],
            "usage": {
              "prompt_tokens": 2574,
              "completion_tokens": 1124,
              "total_tokens": 3698,
              "prompt_tokens_details": {
                "cached_tokens": 2027
              },
              "completion_tokens_details": {
                "reasoning_tokens": 1080,
                "image_tokens": 0
              }
            }
          }
        },
        "score": 0.6666666666666666,
        "ground_truth": {
          "diagnosis": "NF2-related schwannomatosis",
          "assay": "RNA-seq",
          "tumorType": "schwannoma"
        },
        "token_usage": {
          "input_tokens": 2574,
          "output_tokens": 1124,
          "total_tokens": 3698
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 9,
        "input": {
          "diagnosis": "neurofibromatosis type 1 due to NF1 mutation or intragenic deletion",
          "assay": "CellTiter-Glo\u00ae 3D Cell Viability Assay",
          "tumorType": "Epithelioid Malignant Peripheral Nerve Sheath Tumor"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"3D microtissue viability\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```",
          "model_id": "google/gemini-3-pro-preview",
          "usage": {
            "inputTokens": 2598,
            "outputTokens": 1437,
            "totalTokens": 4035
          },
          "attempt": 1,
          "raw_response": {
            "id": "gen-1763583372-OSgx8TmQSXllTxN0ezlN",
            "provider": "Google AI Studio",
            "model": "google/gemini-3-pro-preview",
            "object": "chat.completion",
            "created": 1763583372,
            "choices": [
              {
                "logprobs": null,
                "finish_reason": "stop",
                "native_finish_reason": "STOP",
                "index": 0,
                "message": {
                  "role": "assistant",
                  "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"3D microtissue viability\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```",
                  "refusal": null,
                  "reasoning": "**Mapping Synonyms Now**\n\nI'm currently focused on mapping the user's synonyms to the Target Schema. I'm expanding \"neurofibromatosis type 1\" to include related terms from the controlled vocabulary. The goal is to ensure broader coverage and accurate representation within the metadata. I'm also addressing the assay term, considering potential equivalents or more general categories for consistency.\n\n\n**Refining Assay Mapping**\n\nI'm now refining the assay mapping, moving from a broader \"cell viability assay\" to \"3D microtissue viability\" which seems like a closer match given the explicit \"3D\" in the input. While \"CellTiter-Glo\" is a specific kit, the schema lacks that level of granularity; therefore, I'm focusing on the general assay category. This ensures a consistent approach to different assay variations used in the study.\n\n\n**Assessing Viability Assay**\n\nI've been re-evaluating the \"CellTiter-Glo\" assay from the perspective of schema mapping.  While \"cell viability assay\" is a safe general category, I'm leaning toward \"3D microtissue viability\" because it captures the \"3D\" aspect explicitly mentioned. I'm carefully considering the context to ensure the selected term is the most precise yet broadly applicable within the existing metadata framework.\n\n\n**Revising Assay Choice**\n\nI've been double-checking the assay term, considering the 3D aspect of the \"CellTiter-Glo\" assay. The schema does include \"3D microtissue viability,\" which is more precise. I'm confident in choosing that term to maintain the 3D context. Moving on, I'm analyzing the `tumorType` term \"Epithelioid Malignant Peripheral Nerve Sheath Tumor\" to see how best it fits the existing schema.\n\n\n**Constructing the JSON**\n\nI'm now putting together the final JSON structure based on my previous analysis. I've confirmed that all chosen terms align with the schema. I verified the diagnosis, assay (now solidified as \"3D microtissue viability\"), and the tumor type, which I've mapped to \"Malignant Peripheral Nerve Sheath Tumor\". I'm confident that these mappings accurately represent the input data and will ensure consistency with existing entries.\n\n\n**Confirming Final Mappings**\n\nI've finalized my JSON structure, double-checking against the schema and input. Focusing on `diagnosis`, I've selected the broader \"Neurofibromatosis type 1\" as the most accurate representation of the clinical diagnosis. The assay term is set as before. The `tumorType` is validated. Everything aligns and adheres to the original mappings. The output is ready.\n\n\n",
                  "reasoning_details": [
                    {
                      "format": "google-gemini-v1",
                      "index": 0,
                      "type": "reasoning.text",
                      "text": "**Mapping Synonyms Now**\n\nI'm currently focused on mapping the user's synonyms to the Target Schema. I'm expanding \"neurofibromatosis type 1\" to include related terms from the controlled vocabulary. The goal is to ensure broader coverage and accurate representation within the metadata. I'm also addressing the assay term, considering potential equivalents or more general categories for consistency.\n\n\n**Refining Assay Mapping**\n\nI'm now refining the assay mapping, moving from a broader \"cell viability assay\" to \"3D microtissue viability\" which seems like a closer match given the explicit \"3D\" in the input. While \"CellTiter-Glo\" is a specific kit, the schema lacks that level of granularity; therefore, I'm focusing on the general assay category. This ensures a consistent approach to different assay variations used in the study.\n\n\n**Assessing Viability Assay**\n\nI've been re-evaluating the \"CellTiter-Glo\" assay from the perspective of schema mapping.  While \"cell viability assay\" is a safe general category, I'm leaning toward \"3D microtissue viability\" because it captures the \"3D\" aspect explicitly mentioned. I'm carefully considering the context to ensure the selected term is the most precise yet broadly applicable within the existing metadata framework.\n\n\n**Revising Assay Choice**\n\nI've been double-checking the assay term, considering the 3D aspect of the \"CellTiter-Glo\" assay. The schema does include \"3D microtissue viability,\" which is more precise. I'm confident in choosing that term to maintain the 3D context. Moving on, I'm analyzing the `tumorType` term \"Epithelioid Malignant Peripheral Nerve Sheath Tumor\" to see how best it fits the existing schema.\n\n\n**Constructing the JSON**\n\nI'm now putting together the final JSON structure based on my previous analysis. I've confirmed that all chosen terms align with the schema. I verified the diagnosis, assay (now solidified as \"3D microtissue viability\"), and the tumor type, which I've mapped to \"Malignant Peripheral Nerve Sheath Tumor\". I'm confident that these mappings accurately represent the input data and will ensure consistency with existing entries.\n\n\n**Confirming Final Mappings**\n\nI've finalized my JSON structure, double-checking against the schema and input. Focusing on `diagnosis`, I've selected the broader \"Neurofibromatosis type 1\" as the most accurate representation of the clinical diagnosis. The assay term is set as before. The `tumorType` is validated. Everything aligns and adheres to the original mappings. The output is ready.\n\n\n"
                    },
                    {
                      "format": "google-gemini-v1",
                      "index": 0,
                      "type": "reasoning.encrypted",
                      "data": "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"
                    }
                  ]
                }
              }
            ],
            "usage": {
              "prompt_tokens": 2598,
              "completion_tokens": 1437,
              "total_tokens": 4035,
              "prompt_tokens_details": {
                "cached_tokens": 2027
              },
              "completion_tokens_details": {
                "reasoning_tokens": 1387,
                "image_tokens": 0
              }
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "3D microtissue viability",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
        },
        "token_usage": {
          "input_tokens": 2598,
          "output_tokens": 1437,
          "total_tokens": 4035
        },
        "tool_calls": [],
        "tool_execution_history": []
      }
    ],
    "metrics": {
      "total_samples": 10,
      "successful_runs": 10,
      "failed_runs": 0,
      "success_rate": 1.0,
      "average_score": 0.9333333333333332,
      "min_score": 0.6666666666666666,
      "max_score": 1.0,
      "num_scored": 10
    },
    "duration_seconds": 101.61199283599854,
    "token_usage": {
      "input_tokens": 25759,
      "output_tokens": 10151,
      "total_tokens": 35910
    }
  }
}